ليتروزول تيڤع

Šalis: Izraelis

kalba: arabų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

LETROZOLE 2.5 MG

Prieinama:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kodas:

L02BG04

Vaisto forma:

TABLETS

Vartojimo būdas:

PER OS

Pagaminta:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Farmakoterapinė grupė:

LETROZOLE

Terapinės indikacijos:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Leidimo data:

2010-01-01